Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE2.7300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.5000/ 2
- Ask / Lots3.1800/ 1
- Open / Previous Close2.6600 / 2.7300
- Day Range
- 52 Week Range
- Volume278,605
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 3108 | 2.67 |
| 09:34 ET | 1719 | 2.73 |
| 09:36 ET | 190 | 2.72 |
| 09:39 ET | 721 | 2.74 |
| 09:41 ET | 200 | 2.72 |
| 09:43 ET | 902 | 2.7 |
| 09:45 ET | 1000 | 2.68 |
| 09:48 ET | 500 | 2.675 |
| 09:50 ET | 700 | 2.66 |
| 09:52 ET | 830 | 2.66 |
| 09:54 ET | 14598 | 2.74 |
| 09:56 ET | 300 | 2.745 |
| 09:57 ET | 200 | 2.76 |
| 10:01 ET | 4769 | 2.79 |
| 10:08 ET | 100 | 2.7815 |
| 10:10 ET | 540 | 2.79 |
| 10:12 ET | 800 | 2.78 |
| 10:14 ET | 700 | 2.76 |
| 10:15 ET | 193 | 2.765 |
| 10:17 ET | 200 | 2.75 |
| 10:19 ET | 224 | 2.75 |
| 10:21 ET | 200 | 2.75 |
| 10:24 ET | 100 | 2.75 |
| 10:26 ET | 200 | 2.74 |
| 10:28 ET | 500 | 2.73 |
| 10:30 ET | 2445 | 2.7 |
| 10:32 ET | 607 | 2.68 |
| 10:33 ET | 1973 | 2.69 |
| 10:37 ET | 1871 | 2.69 |
| 10:39 ET | 700 | 2.68 |
| 10:42 ET | 100 | 2.67 |
| 10:44 ET | 100 | 2.68 |
| 10:46 ET | 2606 | 2.7 |
| 10:53 ET | 232 | 2.71 |
| 10:55 ET | 231 | 2.71 |
| 10:57 ET | 328 | 2.71 |
| 11:00 ET | 100 | 2.72 |
| 11:02 ET | 300 | 2.72 |
| 11:04 ET | 1933 | 2.7 |
| 11:06 ET | 375 | 2.7002 |
| 11:08 ET | 100 | 2.7 |
| 11:09 ET | 400 | 2.68 |
| 11:11 ET | 200 | 2.68 |
| 11:13 ET | 373 | 2.685 |
| 11:18 ET | 1225 | 2.665 |
| 11:20 ET | 1706 | 2.66 |
| 11:22 ET | 100 | 2.66 |
| 11:24 ET | 320 | 2.65 |
| 11:26 ET | 200 | 2.655 |
| 11:27 ET | 117 | 2.65 |
| 11:29 ET | 200 | 2.64 |
| 11:31 ET | 1928 | 2.655 |
| 11:33 ET | 119 | 2.655 |
| 11:38 ET | 115 | 2.655 |
| 11:42 ET | 500 | 2.65 |
| 11:44 ET | 379 | 2.64 |
| 11:45 ET | 2180 | 2.645 |
| 11:47 ET | 2284 | 2.66 |
| 11:56 ET | 7335 | 2.69 |
| 11:58 ET | 1910 | 2.685 |
| 12:00 ET | 202 | 2.69 |
| 12:02 ET | 100 | 2.7 |
| 12:03 ET | 110 | 2.695 |
| 12:05 ET | 406 | 2.69 |
| 12:07 ET | 105 | 2.685 |
| 12:12 ET | 100 | 2.685 |
| 12:14 ET | 1245 | 2.684 |
| 12:16 ET | 100 | 2.69 |
| 12:18 ET | 301 | 2.685 |
| 12:20 ET | 400 | 2.685 |
| 12:21 ET | 200 | 2.69 |
| 12:23 ET | 204 | 2.685 |
| 12:25 ET | 500 | 2.685 |
| 12:27 ET | 202 | 2.685 |
| 12:30 ET | 323 | 2.68 |
| 12:32 ET | 5565 | 2.6927 |
| 12:34 ET | 101 | 2.695 |
| 12:36 ET | 12817 | 2.701 |
| 12:38 ET | 3200 | 2.7 |
| 12:41 ET | 2343 | 2.6959 |
| 12:43 ET | 200 | 2.69 |
| 12:45 ET | 1047 | 2.685 |
| 12:48 ET | 100 | 2.685 |
| 12:52 ET | 300 | 2.69 |
| 12:54 ET | 5058 | 2.6901 |
| 01:01 ET | 3795 | 2.7 |
| 01:03 ET | 105 | 2.7 |
| 01:08 ET | 102 | 2.7 |
| 01:10 ET | 100 | 2.7 |
| 01:12 ET | 924 | 2.695 |
| 01:17 ET | 101 | 2.695 |
| 01:19 ET | 800 | 2.69 |
| 01:21 ET | 4790 | 2.6948 |
| 01:24 ET | 101 | 2.695 |
| 01:28 ET | 102 | 2.695 |
| 01:30 ET | 100 | 2.69 |
| 01:32 ET | 200 | 2.69 |
| 01:33 ET | 1398 | 2.69 |
| 01:35 ET | 116 | 2.69 |
| 01:37 ET | 1165 | 2.71 |
| 01:39 ET | 100 | 2.71 |
| 01:44 ET | 305 | 2.71 |
| 01:48 ET | 103 | 2.705 |
| 01:50 ET | 800 | 2.705 |
| 01:51 ET | 700 | 2.705 |
| 01:53 ET | 106 | 2.705 |
| 01:55 ET | 200 | 2.705 |
| 01:57 ET | 105 | 2.705 |
| 02:00 ET | 825 | 2.71 |
| 02:04 ET | 316 | 2.705 |
| 02:06 ET | 100 | 2.7 |
| 02:08 ET | 114 | 2.705 |
| 02:09 ET | 400 | 2.705 |
| 02:13 ET | 315 | 2.705 |
| 02:18 ET | 715 | 2.705 |
| 02:22 ET | 2399 | 2.715 |
| 02:24 ET | 313 | 2.715 |
| 02:27 ET | 115 | 2.715 |
| 02:33 ET | 319 | 2.715 |
| 02:36 ET | 200 | 2.71 |
| 02:38 ET | 5550 | 2.73 |
| 02:40 ET | 400 | 2.73 |
| 02:42 ET | 100 | 2.74 |
| 02:44 ET | 520 | 2.735 |
| 02:47 ET | 932 | 2.74 |
| 02:49 ET | 100 | 2.75 |
| 02:51 ET | 500 | 2.75 |
| 02:54 ET | 322 | 2.75 |
| 02:56 ET | 571 | 2.75 |
| 02:58 ET | 326 | 2.745 |
| 03:00 ET | 2170 | 2.77 |
| 03:02 ET | 100 | 2.77 |
| 03:03 ET | 337 | 2.765 |
| 03:05 ET | 4000 | 2.76 |
| 03:07 ET | 134 | 2.755 |
| 03:09 ET | 700 | 2.75 |
| 03:12 ET | 2974 | 2.755 |
| 03:14 ET | 100 | 2.75 |
| 03:18 ET | 246 | 2.755 |
| 03:20 ET | 300 | 2.75 |
| 03:21 ET | 100 | 2.75 |
| 03:23 ET | 754 | 2.75 |
| 03:27 ET | 256 | 2.75 |
| 03:30 ET | 100 | 2.75 |
| 03:32 ET | 7155 | 2.755 |
| 03:34 ET | 34771 | 2.82 |
| 03:36 ET | 1500 | 2.8 |
| 03:38 ET | 193 | 2.805 |
| 03:39 ET | 200 | 2.79 |
| 03:41 ET | 1200 | 2.79 |
| 03:43 ET | 1070 | 2.78 |
| 03:45 ET | 613 | 2.78 |
| 03:48 ET | 2267 | 2.77 |
| 03:50 ET | 2005 | 2.76 |
| 03:52 ET | 3225 | 2.77 |
| 03:54 ET | 685 | 2.77 |
| 03:56 ET | 2530 | 2.77 |
| 03:57 ET | 4020 | 2.74 |
| 03:59 ET | 2385 | 2.73 |
May 29, 2024
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences, from 4:36PM ET on Wednesday May 29, 2024 by Dow Jones
4:36PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 138.7M | -0.6x | --- |
Acumen Pharmaceuticals Inc | 138.8M | -2.1x | --- |
Cytodyn Inc | 139.1M | -2.5x | --- |
Elevation Oncology Inc | 139.9M | -2.4x | --- |
Atossa Therapeutics Inc | 142.1M | -4.5x | --- |
Yubo International Biotech Ltd | 137.8M | -111.5x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $138.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.38 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
